Fresenius Kabi Polskasp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-06-27
Share capital
27 130 000,00 PLN
Registered address
Aleje Jerozolimskie 134, 02-305 Warszawa, Poland
Electronic delivery address
AE:PL-67724-36747-WHBVA-19

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 247.10mMedianUSD 816.16kAverageUSD 29.28m
Net profit
This companyUSD 33.38mMedianUSD 8.96kAverageUSD 2.64m
Operating costs
This companyUSD 198.98mMedianUSD 701.47kAverageUSD 19.26m
Assets
This companyUSD 236.96mMedianUSD 800.13kAverageUSD 29.34m

Bank accounts

Registered as a VAT taxpayer on 2003-11-30. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

Publication dateEvent
Jul 22, 2026Return of additional payments
Feb 28, 2014Merger plan
May 6, 2013Merger plan

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$13,949
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$12,059

Tenders

2237 tenders recorded as contractor: 475 national ($20,948,968) and 1762 EU ($4,682,000,410).

SubjectAmount
Dostawa leków do chemioterapii i programów lekowych 2026-2028
—
Dostawa leków programowych, onkologicznych, płynów infuzyjnych, erytropoetyny oraz kontrastów
—
Dostawy zestawów do filtracji (tzw. ośmiorniczek) przeznaczonych do otrzymywania ubogoleukocytarnego koncentratu krwinek płytkowych (UKKP).
—

Authorized Representatives

Magdalena Aleksandra Przygodzka — Attorney-in-fact (joint)
Maciej Henryk Chmielowski — Management Board Member
Izabella Grabska — Attorney-in-fact (joint)
Tomasz Michał Halik — Management Board Member

Manner of representation

In the case of a multi-member management board, two members of the management board jointly or one member of the management board jointly with a commercial proxy.

Ownership

OwnerSharesShare valueStake
Fresenius Kabi Ag
226,080$3,053,484.6041.6661%
Others
316,520$4,274,986.4958.3339%

Beneficial owners

Person
Maciej Henryk Chmielowski (65)
Tomasz Michał Halik (49)

Subsidiaries

NameStake
Dom Medicasp. z o.o.
99.99%

Competitors

Change history

DateEvent
2018-12-06Address change
2015-12-02Address change
2012-11-27Share capital change
2009-09-07Share capital change
2005-06-07Address change

FAQ

Last updated: 2026-07-15